Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M. Goldman

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Chinese Medical Journal|July 22, 2004
Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosomeZi-xing Chen, Jaspal Kaeda, Sue Saunders, et al.
Respirology (Carlton, Vic.)|June 16, 2005
Pneumocystis carinii pneumonia infection in a patient with known chronic mucocutaneous candidiasisDamian J McKeon, William White, David Sinclair, et al.
Blood|October 23, 2010
Three decades of transplantation for chronic myeloid leukemia: what have we learned?Jirí Pavlu, Richard M Szydlo, John M Goldman, et al.
British Journal of Haematology|February 14, 2002
Effects of combinations of therapeutic agents on the proliferation of progenitor cells in chronic myeloid leukaemiaStephen B Marley, R John Davidson, John M Goldman, et al.
Experimental Hematology|October 31, 2003
Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylateAlex J Tipping, Michael W Deininger, John M Goldman, et al.
British Journal of Haematology|September 27, 2003
Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myelomaEvangelos Terpos, Marianna Politou, Richard Szydlo, et al.
Blood|February 28, 2002
Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanismBeate Schultheis, Melina Carapeti-Marootian, Andreas Hochhaus, et al.
Blood|September 8, 2005
Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CMLAgnes S M Yong, Richard M Szydlo, John M Goldman, et al.
Blood|May 3, 2002
Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantationEduardo Olavarria, Charles Craddock, Francesco Dazzi, et al.
Haematologica|September 10, 2002
The use of imatinib (STI571) in chronic myelod leukemia: some practical considerationsDavid Marin, Sarah Marktel, Marco Bua, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Chinese Medical Journal|July 22, 2004
Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosomeZi-xing Chen, Jaspal Kaeda, Sue Saunders, et al.
Respirology (Carlton, Vic.)|June 16, 2005
Pneumocystis carinii pneumonia infection in a patient with known chronic mucocutaneous candidiasisDamian J McKeon, William White, David Sinclair, et al.
Blood|October 23, 2010
Three decades of transplantation for chronic myeloid leukemia: what have we learned?Jirí Pavlu, Richard M Szydlo, John M Goldman, et al.
British Journal of Haematology|February 14, 2002
Effects of combinations of therapeutic agents on the proliferation of progenitor cells in chronic myeloid leukaemiaStephen B Marley, R John Davidson, John M Goldman, et al.
Experimental Hematology|October 31, 2003
Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylateAlex J Tipping, Michael W Deininger, John M Goldman, et al.
British Journal of Haematology|September 27, 2003
Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myelomaEvangelos Terpos, Marianna Politou, Richard Szydlo, et al.
Blood|February 28, 2002
Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanismBeate Schultheis, Melina Carapeti-Marootian, Andreas Hochhaus, et al.
Blood|September 8, 2005
Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CMLAgnes S M Yong, Richard M Szydlo, John M Goldman, et al.
Blood|May 3, 2002
Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantationEduardo Olavarria, Charles Craddock, Francesco Dazzi, et al.
Haematologica|September 10, 2002
The use of imatinib (STI571) in chronic myelod leukemia: some practical considerationsDavid Marin, Sarah Marktel, Marco Bua, et al.
Pageof 10